Amarantus Bioscience Holdings Stock Current Valuation
| AMBS Stock | USD 0.0001 0.00 0.00% |
Valuation analysis of Amarantus Bioscience helps investors to measure Amarantus Bioscience's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Undervalued
Today
Please note that Amarantus Bioscience's price fluctuation is out of control at this time. Calculation of the real value of Amarantus Bioscience is based on 3 months time horizon. Increasing Amarantus Bioscience's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Amarantus pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Amarantus Bioscience Holdings. Since Amarantus Bioscience is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Amarantus Pink Sheet. However, Amarantus Bioscience's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 2.12E-4 | Hype 9.6E-5 |
The intrinsic value of Amarantus Bioscience's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Amarantus Bioscience's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Amarantus Bioscience Holdings helps investors to forecast how Amarantus pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Amarantus Bioscience more accurately as focusing exclusively on Amarantus Bioscience's fundamentals will not take into account other important factors: Amarantus Bioscience Holdings Company Current Valuation Analysis
Amarantus Bioscience's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Amarantus Bioscience Current Valuation | 6.59 M |
Most of Amarantus Bioscience's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Amarantus Bioscience Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Amarantus Bioscience Holdings has a Current Valuation of 6.59 M. This is 99.95% lower than that of the Biotechnology sector and 99.86% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.96% higher than that of the company.
Amarantus Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amarantus Bioscience's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Amarantus Bioscience could also be used in its relative valuation, which is a method of valuing Amarantus Bioscience by comparing valuation metrics of similar companies.Amarantus Bioscience is currently under evaluation in current valuation category among its peers.
Amarantus Fundamentals
| Current Valuation | 6.59 M | |||
| Shares Outstanding | 68.27 M | |||
| Price To Earning | (0.01) X | |||
| Price To Book | 53.19 X | |||
| EBITDA | (20.79 M) | |||
| Net Income | (10.58 M) | |||
| Cash And Equivalents | 178 | |||
| Total Debt | 20.72 M | |||
| Debt To Equity | 0.84 % | |||
| Current Ratio | 0.02 X | |||
| Book Value Per Share | (0.12) X | |||
| Cash Flow From Operations | (1.8 M) | |||
| Earnings Per Share | (0.03) X | |||
| Target Price | 9.0 | |||
| Number Of Employees | 19 | |||
| Beta | 1.67 | |||
| Market Capitalization | 3.13 M | |||
| Total Asset | 3.48 M | |||
| Retained Earnings | (104.87 M) | |||
| Working Capital | (14.89 M) | |||
| Current Asset | 942 K | |||
| Current Liabilities | 15.83 M | |||
| Z Score | -63.3 | |||
| Net Asset | 3.48 M |
About Amarantus Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Amarantus Bioscience Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amarantus Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amarantus Bioscience Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Amarantus Pink Sheet Analysis
When running Amarantus Bioscience's price analysis, check to measure Amarantus Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amarantus Bioscience is operating at the current time. Most of Amarantus Bioscience's value examination focuses on studying past and present price action to predict the probability of Amarantus Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amarantus Bioscience's price. Additionally, you may evaluate how the addition of Amarantus Bioscience to your portfolios can decrease your overall portfolio volatility.